Mediclinic International PLC (LON:MDC) had its price target decreased by investment analysts at Jefferies Group from GBX 812 ($10.07) to GBX 741 ($9.19) in a report released on Tuesday. The brokerage currently has a “hold” rating on the stock. Jefferies Group’s price target indicates a potential upside of 1.16% from the stock’s previous close.

Several other brokerages have also recently issued reports on MDC. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 1,160 ($14.39) price objective on shares of Mediclinic International PLC in a research note on Tuesday, August 23rd. HSBC cut their price objective on Mediclinic International PLC from GBX 920 ($11.41) to GBX 745 ($9.24) and set a “reduce” rating on the stock in a research note on Friday, November 11th. Citigroup Inc. cut Mediclinic International PLC to a “neutral” rating and set a GBX 1,090 ($13.52) price objective on the stock. in a research note on Monday, September 12th. Credit Suisse Group AG cut their price objective on Mediclinic International PLC from GBX 1,120 ($13.89) to GBX 1,045 ($12.96) and set an “outperform” rating on the stock in a research note on Friday, November 11th. Finally, Macquarie cut their price objective on Mediclinic International PLC from GBX 970 ($12.03) to GBX 830 ($10.30) and set a “neutral” rating on the stock in a research note on Wednesday, November 23rd. One analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company’s stock. Mediclinic International PLC currently has an average rating of “Hold” and an average price target of GBX 933.33 ($11.58).

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Shares of Mediclinic International PLC (LON:MDC) opened at 722.50 on Tuesday. The company has a 50 day moving average price of GBX 845.21 and a 200-day moving average price of GBX 949.09. The stock’s market capitalization is GBX 5.33 billion. Mediclinic International PLC has a 1-year low of GBX 721.50 and a 1-year high of GBX 1,174.00.

The firm also recently announced a dividend, which will be paid on Monday, December 12th. Investors of record on Thursday, November 24th will be given a GBX 3.20 ($0.04) dividend. This represents a yield of 0.41%. The ex-dividend date of this dividend is Thursday, November 24th.

TRADEMARK VIOLATION NOTICE: “Jefferies Group Lowers Mediclinic International PLC (MDC) Price Target to GBX 741” was reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright law. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/29/jefferies-group-lowers-mediclinic-international-plc-mdc-price-target-to-gbx-741.html.

Mediclinic International PLC Company Profile

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Stock Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related stocks with our FREE daily email newsletter.